Letter: combination of biologics in inflammatory bowel diseases. Authors' reply.
作者信息
Yang Edward, Panaccione Nicola, Whitmire Natalie, Dulai Parambir S, Vande Casteele Niels, Singh Siddharth, Boland Brigid S, Collins Angelina, Sandborn William J, Panaccione Remo, Battat Robert
机构信息
Division of Gastroenterology, Department of Medicine, UCSD Inflammatory Bowel Disease Center, La Jolla, CA, USA.
Faculty of Health Science, Western University, London, ON, Canada.
出版信息
Aliment Pharmacol Ther. 2020 Aug;52(3):568-569. doi: 10.1111/apt.15919.
PMID:32656846
Abstract
摘要
相似文献
1
Letter: combination of biologics in inflammatory bowel diseases. Authors' reply.
Aliment Pharmacol Ther. 2020 Aug;52(3):568-569. doi: 10.1111/apt.15919.
2
Letter: combination of biologics in inflammatory bowel diseases.
Aliment Pharmacol Ther. 2020 Aug;52(3):566-567. doi: 10.1111/apt.15891.
3
Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy? Authors' reply.
Aliment Pharmacol Ther. 2018 Jan;47(1):147-148. doi: 10.1111/apt.14398.
4
Letter: biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease - authors' reply.
Aliment Pharmacol Ther. 2016 Jun;43(11):1246. doi: 10.1111/apt.13606.
5
Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease-Authors' reply.
Aliment Pharmacol Ther. 2020 Jul;52(1):216-217. doi: 10.1111/apt.15806.
6
Editorial: paradoxical skin lesions during anti-TNF treatment-an additional argument to consider new biologics as first-line therapy in inflammatory bowel disease. Authors' reply.
Aliment Pharmacol Ther. 2018 Sep;48(6):684-685. doi: 10.1111/apt.14917.
7
Letter: immunogenicity of infliximab-ready for routine prediction? Authors' reply.
Aliment Pharmacol Ther. 2020 Apr;51(8):813-814. doi: 10.1111/apt.15684.
8
Letter: overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it! Authors' reply.
Aliment Pharmacol Ther. 2018 Nov;48(9):1029-1030. doi: 10.1111/apt.14974.
9
Editorial: keep calm and carry on-managing non-TNF antagonist biologics in pregnancy-authors' reply.
Aliment Pharmacol Ther. 2021 Feb;53(3):452-453. doi: 10.1111/apt.16230.
10
Letter: immunogenicity of anti-TNF in elderly IBD patients-authors' reply.
Aliment Pharmacol Ther. 2019 Aug;50(3):337. doi: 10.1111/apt.15379.
Zotero 插件